FDA Clears First Autoinjectable Testosterone Xyosted

03 Oct, 2018 ,

The US Food and Drug Administration FDA has approved testosterone enanthate Xyosted Antares Pharma subcutaneous injection for testosterone replacement therapy in men diagnosed with conditions associated with a deficiency or absence of endogenous testosterone Xyosted is the first FDAapproved subcutaneous testosterone enanthate product for onceweekly selfadministration using a disposable autoinjector the company said in a news release